1. AB0439 Contribution of anti-ferritin antibodies to the diagnosis of giant cell arteritis. (23rd January 2014) Authors: Regent, A.; Ly, K. H.; Blet, A.; Agard, C.; Puéchal, X.; Tamas, N.; Le-Jeunne, C.; Vidal, E.; Guillevin, L.; Mouthon, L. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A922 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0453 Presentation and management of granulomatosis with polyangiitis (wegener's) (gpa) central nervous system (cns) involvement. (23rd January 2014) Authors: De Luna, G.; Terrier, B.; Charles, P.; Pagnoux, C.; Puéchal, X.; Cohen, P.; Mouthon, L.; Guillevin, L. Journal: Annals of the rheumatic diseases Issue: Volume 72:Supplement 3(2013) Page Start: A927 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. AB0467 REMISSION AND LOW DISEASE ACTIVITY STATE IN PATIENTS WITH GRANULOMATOSIS WITH POLYANGIITIS AND MICROSCOPIC POLYANGIITIS: PREVALENCE AND IMPACT ON DAMAGE ACCRUAL. (2nd June 2020) Authors: Delvino, P.; Sardanelli, F.; Monti, S.; Cohen, P.; Puéchal, X.; Montecucco, C.; Mouthon, L.; Guillevin, L.; Terrier, B. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 1531 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. AB0620 High risk of mistaken classification of primary antiphospholipid syndrome as systemic lupus erythematosusaccording to the slicc criteria: analysis of a cohort of 214 antiphospholipid patients. (12th June 2018) Authors: Paule, R.; Costedoat-Chalumeau, N.; MOREL, N.; LE GUERN, V.; Fredi, M.; Coutte, L.; Belhocine, M.; Mouthon, L.; Le Jeunne, C.; Chauvin, A.; Piette, J.-C. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 1459 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AB0727 There is a Need for New Systemic Sclerosis Subset Criteria. A Content Analytic Approach. (9th June 2015) Authors: Johnson, S.R.; Fransen, J.; Khanna, D.; van den Hoogen, F.; Baron, M.; Matucci-Cerinic, M.; Denton, C.; Medsger, T.A.; Carreira, P.; Riemekasten, G.; Distler, J.; Gabrielli, A.; Steen, V.; Chung, L.; Silver, R.; Varga, J.; Muller-Ladner, U.; Vonk, M.; Walker, U.; Wollheim, F. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1141 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. AB0787 Influence of digital ulcer healing on disability and daily activity limitations in systemic sclerosis. (23rd January 2014) Authors: Berezne, A.; Seror, R.; Bussone, G.; Morell-Dubois, S.; Guillevin, L.; Mouthon, L. Journal: Annals of the rheumatic diseases Issue: Volume 71(2012)Supplement 3 Page Start: 683 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. AB0984 Development of a Juvenile Systemic Sclerosis Response Index (JSSRI). (9th June 2015) Authors: Foeldvari, I.; Györgyi, Z.; Baildam, E.; Batu, E.D.; Blakley, M.; Cakan, M.; Curran, M.; Fligelstone, K.; Mouthon, L.; Nemcova, D.; Pilkington, C.; Ruperto, N.; Tsinti, M.; Tsitsami, E.; Urbanvica, K.; Constantin, T. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1227 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Development and validation of a patient‐reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale. (1st January 2022) Authors: Sibeoni, J.; Dunogué, B.; Dupont, A.; Haiddar, D.; Benmostefa, N.; Falissard, B.; Mouthon, L.; Révah‐Levy, A.; Verneuil, L. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Development and validation of a patient‐reported outcome in systemic sclerosis: the Hand scleroDerma lived Experience (HAnDE) scale. (21st October 2021) Authors: Sibeoni, J.; Dunogué, B.; Dupont, A.; Haiddar, D.; Benmostefa, N.; Falissard, B.; Mouthon, L.; Révah‐Levy, A.; Verneuil, L. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 96 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Development of a new patient‐reported outcome measure to assess activities and participation in people with systemic sclerosis: the Cochin 17‐item Scleroderma Functional scale. (18th March 2020) Authors: Daste, C.; Abdoul, H.; Foissac, F.; Papelard, A.; Alami, S.; Kwakkenbos, L.; Carrier, M.‐E.; Lefèvre‐Colau, M.‐M.; Thombs, B.D.; Poiraudeau, S.; Rannou, F.; Mouthon, L.; Nguyen, C. Journal: British journal of dermatology Issue: Volume 183:Number 4(2020) Page Start: 710 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗